National Standard of the P.R.C., Implants for surgery — Active implantable medical devices — Part 2: Cardiac pacemakers CHN1723

1.

Notifying Member: CHINA

If applicable, name of local government involved (Article 3.2 and 7.2): 

2.

Agency responsible: 

State Administration for Market Regulation (Standardization Administration of the P.R.C.)

Name and address (including telephone and fax numbers, email and website addresses, if available) of agency or authority designated to handle comments regarding the notification shall be indicated if different from above: 

3.

Notified under Article 2.9.2 [X], 2.10.1 [ ], 5.6.2 [ ], 5.7.1 [ ], 3.2 [ ], 7.2 [ ], other: 

4.

Products covered (HS or CCCN where applicable, otherwise national tariff heading. ICS numbers may be provided in addition, where applicable): Active implantable medical devices (HS code(s): 902150); (ICS code(s): 11.040.40)

5.

Title, number of pages and language(s) of the notified document: National Standard of the P.R.C., Implants for surgery — Active implantable medical devices — Part 2: Cardiac pacemakers; (55 page(s), in Chinese)

6.

Description of content: This document specifies requirements for cardiac pacemakers.

This document applies to those active implantable medical devices intended to treat bradyarrhythmias and devices that provide therapies for cardiac resynchronization.

This document also applies to some non-implantable parts and accessories of the devices.

The tests that are specified in this document are type tests, and are to be carried out on samples of a device to show compliance.

The electrical characteristics of the implantable pulse generator or lead are determined either by the appropriate method detailed in this particular document or by any other method demonstrated to have an accuracy equal to, or better than, the method specified. In case of dispute, the method detailed in this particular document applies.

NOTE

The device that is commonly referred to as an active implantable medical device can in fact be a single device, a combination of devices, or a combination of a device or devices and one or more accessories. Not all of these parts are required to be either partially or totally implantable, but there is a need to specify some requirements of non-implantable parts and accessories if they could affect the safety or performance of the implantable device.

7.

Objective and rationale, including the nature of urgent problems where applicable: Protection of human health or safety; Protection of the environment; Quality requirements

8.

Relevant documents: 

-

9.

Proposed date of adoption: To be determined

Proposed date of entry into force: 24 months after approval

10.

Final date for comments: 60 days from notification

11.

Texts available from: National enquiry point [X] or address, telephone and fax numbers and email and website addresses, if available, of other body: 

WTO/TBT National Notification and Enquiry Center of the People's Republic of China

Tel：+86 10 57954633/ 57954627

E_mail: tbt@customs.gov.cn

https://members.wto.org/crnattachments/2023/TBT/CHN/23_8859_00_x.pdf